{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:03:42Z","timestamp":1769263422704,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Tibial fracture is associated with inflammatory reaction leading to severe pain syndrome. Bradykinin receptor activation is involved in inflammatory reactions, but has never been investigated in fracture pain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study aims at defining the role of B1 and B2-kinin receptors (B1R and B2R) in a closed tibial fracture pain model by using knockout mice for B1R (B1KO) or B2R (B2KO) and wild-type (WT) mice treated with antagonists for B1R (SSR 240612 and R954) and B2R (HOE140) or vehicle. A cyclooxygenase (COX) inhibitor (ketoprofen) and an antagonist (SB366791) of Transient Receptor Potential Vaniloid1 (TRPV1) were also investigated since these pathways are associated with BK-induced pain in other models. The impact on mechanical and thermal hyperalgesia and locomotion was assessed by behavior tests. Gene expression of B1R and B2R and spinal cord expression of c-Fos were measured by RT-PCR and immunohistochemistry, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>B1KO and B2KO mice demonstrated a reduction in post-fracture pain sensitivity compared to WT mice that was associated with decreased c-Fos expression in the ipsilateral spinal dorsal horn in B2KO. B1R and B2R mRNA and protein levels were markedly enhanced at the fracture site. B1R and B2R antagonists and inhibition of COX and TRPV1 pathways reduced pain in WT. However, the analgesic effect of the COX-1\/COX-2 inhibitor disappeared in B1KO and B2KO. In contrast, the analgesic effect of the TRPV1 antagonist persisted after gene deletion of either receptor.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>It is suggested that B1R and B2R activation contributes significantly to tibial fracture pain through COX. Hence, B1R and B2R antagonists appear potential therapeutic agents to manage post fracture pain.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12967-019-2095-9","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T04:28:23Z","timestamp":1571804903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Tibial post fracture pain is reduced in kinin receptors deficient mice and blunted by kinin receptor antagonists"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0516-4939","authenticated-orcid":false,"given":"Vincent","family":"Minville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Mouledous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Acil","family":"Jaafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9jean","family":"Couture","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Brouchet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Frances","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Tack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Girolami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"2095_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2012.04.002","volume":"135","author":"D Regoli","year":"2012","unstructured":"Regoli D, Plante GE, Gobeil F Jr. Impact of kinins in the treatment of cardiovascular diseases. Pharmacol Ther. 2012;135:94\u2013111.","journal-title":"Pharmacol Ther"},{"key":"2095_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3959(00)00335-3","volume":"87","author":"JB Calixto","year":"2000","unstructured":"Calixto JB, Cabrini DA, Ferreira J, Campos MM. Kinin in pain and inflammation. Pain. 2000;87:1\u20135.","journal-title":"Pain"},{"key":"2095_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0014-2999(01)01318-8","volume":"429","author":"R Couture","year":"2001","unstructured":"Couture R, Harrisson M, Vianna RM, Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol. 2001;429:161\u201376.","journal-title":"Eur J Pharmacol"},{"key":"2095_CR4","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.biocel.2006.11.016","volume":"39","author":"K Okuse","year":"2007","unstructured":"Okuse K. Pain signalling pathways: from cytokines to ion channels. Int J Biochem Cell Biol. 2007;39:490\u20136.","journal-title":"Int J Biochem Cell Biol"},{"key":"2095_CR5","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1152\/physrev.00048.2010","volume":"92","author":"G Petho","year":"2012","unstructured":"Petho G, Reeh PW. Sensory and signalling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors. Physiol Rev. 2012;92:1699\u2013775.","journal-title":"Physiol Rev"},{"key":"2095_CR6","doi-asserted-by":"publisher","first-page":"8140","DOI":"10.1073\/pnas.120035997","volume":"97","author":"JB Pesquero","year":"2000","unstructured":"Pesquero JB, Araujo RC, Heppenstall PA, Stucky CL, Silva JA Jr, Walther T, Oliveira SM, Pesquero JL, Paiva AC, Calixto JB, Lewin GR, Bader M. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci USA. 2000;97:8140\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2095_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0304-3959(97)03343-5","volume":"71","author":"NM Rupniak","year":"1997","unstructured":"Rupniak NM, Boyce S, Webb JK, Williams AR, Carlson EJ, Hill RG, Borkowski JA, Hess JF. Effects of the bradykinin B1 receptor antagonist des-Arg9[Leu8]bradykinin and genetic disruption of the B2 receptor on nociception in rats and mice. Pain. 1997;71:89\u201397.","journal-title":"Pain"},{"key":"2095_CR8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0896-6273(04)00150-3","volume":"41","author":"M Bandell","year":"2004","unstructured":"Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ, Earley TJ, Patapoutian A. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron. 2004;41:849\u201357.","journal-title":"Neuron"},{"key":"2095_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/sj.bjp.0705546","volume":"141","author":"J Ferreira","year":"2004","unstructured":"Ferreira J, da Silva GL, Calixto JB. Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br J Pharmacol. 2004;141:787\u201394.","journal-title":"Br J Pharmacol"},{"key":"2095_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/ALN.0b013e3181649333","volume":"108","author":"V Minville","year":"2008","unstructured":"Minville V, Laffosse JM, Fourcade O, Girolami JP, Tack I. Mouse model of fracture pain. Anesthesiology. 2008;108:467\u201372.","journal-title":"Anesthesiology"},{"key":"2095_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00005131-199404000-00006","volume":"8","author":"Y An","year":"1994","unstructured":"An Y, Friedman RJ, Parent T, Draughn RA. Production of a standard closed fracture in the rat tibia. J Orthop Trauma. 1994;8:111\u20135.","journal-title":"J Orthop Trauma"},{"issue":"5","key":"2095_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1468-1331.2010.02947.x","volume":"17","author":"C Maih\u00f6fner","year":"2010","unstructured":"Maih\u00f6fner C, Seifert F, Markovic K. Complex regional pain syndromes: new pathophysiological concepts and therapies. Eur J Neurol. 2010;17(5):649\u201360.","journal-title":"Eur J Neurol"},{"key":"2095_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pain.2003.12.010","volume":"108","author":"TZ Guo","year":"2004","unstructured":"Guo TZ, Offley SC, Boyd EA, Jacobs CR, Kingery WS. Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional syndrome type I. Pain. 2004;108:95\u2013107.","journal-title":"Pain"},{"key":"2095_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.pain.2007.10.013","volume":"137","author":"I Sabsovich","year":"2008","unstructured":"Sabsovich I, Guo TZ, Wei T, Zhao R, Li X, Clark DJ, Geis C, Sommer C, Kingery WS. TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain. 2008;137:507\u201319.","journal-title":"Pain"},{"key":"2095_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pain.2007.11.004","volume":"138","author":"I Sabsovich","year":"2008","unstructured":"Sabsovich I, Wei T, Guo TZ, Zhao R, Shi X, Li X, Yeomans DC, Klyukinov M, Kingery WS, Clark JD. Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain. 2008;138:47\u201360.","journal-title":"Pain"},{"key":"2095_CR16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.pain.2010.09.026","volume":"151","author":"WW Li","year":"2010","unstructured":"Li WW, Guo TZ, Li XQ, Kingery WS, Clark JD. Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators. Pain. 2010;151:843\u201352.","journal-title":"Pain"},{"key":"2095_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pain.2009.09.032","volume":"147","author":"WW Li","year":"2009","unstructured":"Li WW, Guo TZ, Liang D, Shi X, Wei T, Kingery WS, Clark JD. The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome. Pain. 2009;147:277\u201386.","journal-title":"Pain"},{"key":"2095_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/ALN.0b013e31824bb303","volume":"116","author":"WW Li","year":"2012","unstructured":"Li WW, Guo TZ, Liang DY, Sun Y, Kingery WS, Clark JD. Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome. Anesthesiology. 2012;116:882\u201395.","journal-title":"Anesthesiology"},{"key":"2095_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pain.2009.04.033","volume":"144","author":"WW Li","year":"2009","unstructured":"Li WW, Sabsovich I, Guo TZ, Zhao R, Kingery WS, Clark JD. The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome. Pain. 2009;144:303\u201313.","journal-title":"Pain"},{"key":"2095_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.pain.2009.04.020","volume":"144","author":"T Wei","year":"2009","unstructured":"Wei T, Li WW, Guo TZ, Zhao R, Wang L, Clark DJ, Oaklander AL, Schmelz M, Kingery WS. Post-junctional facilitation of substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I. Pain. 2009;144:278\u201386.","journal-title":"Pain"},{"key":"2095_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.bjp.0706012","volume":"143","author":"JB Calixto","year":"2004","unstructured":"Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol. 2004;143:803\u201318.","journal-title":"Br J Pharmacol"},{"key":"2095_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0304-3959(99)00152-9","volume":"83","author":"A Eckert","year":"1999","unstructured":"Eckert A, Segond von Banchet G, Sopper S, Petersen M. Spatio-temporal pattern of induction of bradykinin receptors and inflammation in rat dorsal root ganglia after unilateral nerve ligation. Pain. 1999;83:487\u201397.","journal-title":"Pain"},{"key":"2095_CR23","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1172\/JCI1359","volume":"101","author":"JP Schanstra","year":"1998","unstructured":"Schanstra JP, Bataill\u00e9 E, Marin Casta\u00f1o ME, Barascud Y, Hirtz C, Pesquero JB, Pecher C, Gauthier F, Girolami JP, Bascands JL. The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts. J Clin Invest. 1998;101:2080\u201391.","journal-title":"J Clin Invest"},{"key":"2095_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.expneurol.2011.11.032","volume":"234","author":"S Talbot","year":"2012","unstructured":"Talbot S, Couture R. Emerging role of microglial kinin B1 receptor in diabetic pain neuropathy. Exp Neurol. 2012;234:373\u201381.","journal-title":"Exp Neurol"},{"key":"2095_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","volume":"16","author":"M Zimmermann","year":"1983","unstructured":"Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109\u201310.","journal-title":"Pain"},{"key":"2095_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0304-3959(90)90022-6","volume":"41","author":"N Attal","year":"1990","unstructured":"Attal N, Jazat F, Kayser V, Guilbaud G. Further evidence for \u2018pain-related\u2019 behaviours in a model of unilateral peripheral mononeuropathy. Pain. 1990;41:235\u201351.","journal-title":"Pain"},{"key":"2095_CR27","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/00000542-199411000-00024","volume":"81","author":"KC Lee","year":"1994","unstructured":"Lee KC, Wilder RT, Smith RL, Berde CB. Thermal hyperalgesia accelerates and MK-801 prevents the development of tachyphylaxis to rat sciatic nerve blockade. Anesthesiology. 1994;81:1284\u2013327.","journal-title":"Anesthesiology"},{"key":"2095_CR28","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/syn.20774","volume":"64","author":"L Moul\u00e9dous","year":"2010","unstructured":"Moul\u00e9dous L, Frances B, Zajac JM. Modulation of basal and morphine-induced neuronal activity by a NPFF(2) selective agonist measured by c-Fos mapping of the mouse brain. Synapse. 2010;64:672\u201381.","journal-title":"Synapse"},{"key":"2095_CR29","doi-asserted-by":"publisher","first-page":"F1249","DOI":"10.1152\/ajprenal.00501.2007","volume":"294","author":"M Bul\u00e9on","year":"2008","unstructured":"Bul\u00e9on M, Allard J, Jaafar A, Praddaude F, Dickson Z, Ranera MT, Pecher C, Girolami JP, Tack I. Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db\/db mice model. Am J Physiol Renal Physiol. 2008;294:F1249\u201356.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2095_CR30","doi-asserted-by":"publisher","first-page":"F293","DOI":"10.1152\/ajprenal.00437.2011","volume":"303","author":"N Blaes","year":"2012","unstructured":"Blaes N, P\u00e9cher C, Mehrenberger M, Cellier E, Praddaude F, Chevalier J, Tack I, Couture R, Girolami JP. Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesengial cells through the B2-kinin receptor. Am J Physiol Renal Physiol. 2012;303:F293\u2013303.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2095_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pain.2007.06.016","volume":"133","author":"JM Jimenez-Andrade","year":"2007","unstructured":"Jimenez-Andrade JM, Martin CD, Koewler NJ, Freeman KT, Sullivan LJ, Halvorson KG, Barthold CM, Peters CM, Buus RJ, Ghilardi JR, Lewis JL, Kuskowski MA, Mantyh PW. Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture. Pain. 2007;133:183\u201396.","journal-title":"Pain"},{"issue":"Suppl 3","key":"2095_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1054\/jpai.2000.9807a","volume":"1","author":"JN Wood","year":"2000","unstructured":"Wood JN, Heath MJ. Molecules that specify modality: mechanism of nociception. J Pain. 2000;1(Suppl 3):19\u201325.","journal-title":"J Pain"},{"key":"2095_CR33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-2094-9-16","volume":"9","author":"S Talbot","year":"2012","unstructured":"Talbot S, Dias JP, Lahjouji K, Bogo MR, Campos MM, Gaudreau P, Couture R. Activation of TRPV1 by capsaicin induces functional kinin B1 receptor in rat spinal cord microglia. J Neuroinflamm. 2012;9:16\u201333.","journal-title":"J Neuroinflamm"},{"key":"2095_CR34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/ALN.0b013e318242b2ea","volume":"116","author":"C Cayla","year":"2012","unstructured":"Cayla C, Labuz D, Machelska H, Bader M, Sch\u00e4fer M, Stein C. Impaired nociception and peripheral opioid antinociception in mice lacking both kinin B1 and B2 receptors. Anesthesiology. 2012;116:448\u201357.","journal-title":"Anesthesiology"},{"key":"2095_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0162-3109(96)00101-4","volume":"33","author":"S Boyce","year":"1996","unstructured":"Boyce S, Rupniak NM, Carlson EJ, Webb J, Borkowski JA, Hess JF, Strader CD, Hill RG. Nociception and inflammatory hyperalgesia in B2 bradykinin receptor knockout mice. Immunopharmacology. 1996;33:333\u20135.","journal-title":"Immunopharmacology"},{"key":"2095_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1515\/hsz-2012-0305","volume":"394","author":"S Grastilleur","year":"2013","unstructured":"Grastilleur S, Mouledous L, Bedel J, Etcheverry J, Bader M, Girolami JP, Fourcade O, Frances B, Minville V. Role of kinin B2 receptors in opioid-induced hyperalgesia in inflammatory pain in mice. Biol Chem. 2013;394:361\u20138.","journal-title":"Biol Chem"},{"key":"2095_CR37","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/j.1476-5381.1992.tb13418.x","volume":"107","author":"A Dray","year":"1992","unstructured":"Dray A, Patel IA, Perkins MN, Rueff A. Bradykinin-induced activation of nociceptors: receptor and mechanistic studies on the neonatal rat spinal cord-tail preparation in vitro. Br J Pharmacol. 1992;107:1129\u201334.","journal-title":"Br J Pharmacol"},{"key":"2095_CR38","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/j.1476-5381.1996.tb15562.x","volume":"118","author":"CL Davis","year":"1996","unstructured":"Davis CL, Naeem S, Phagoo SB, Campbell EA, Urban L, Burgess GM. B1 bradykinin receptors and sensory neurones. Br J Pharmacol. 1996;118:1469\u201376.","journal-title":"Br J Pharmacol"},{"key":"2095_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1476-5381.1993.tb13464.x","volume":"108","author":"CG Heapy","year":"1993","unstructured":"Heapy CG, Shaw JS, Farmer SC. Differential sensitivity of antinociceptive assays to the Bradykinin anatgonist Hoe14. Br J Pharmacol. 1993;108:209\u2013301.","journal-title":"Br J Pharmacol"},{"key":"2095_CR40","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1073\/pnas.85.9.3245","volume":"85","author":"LR Steranka","year":"1988","unstructured":"Steranka LR, Manning DC, DeHaas CJ, Ferkany JW, Borosky SA, Connor JR, Vavrek RJ, Stewart JM, Snyder SH. Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci USA. 1988;85:3245\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2095_CR41","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/BF00165756","volume":"336","author":"ET Whalley","year":"1987","unstructured":"Whalley ET, Clegg S, Stewart JM, Vavrek RJ. The effect of kinin agonists and antagonists on the pain response of the human blister base. Naunyn Schmiedebergs Arch Pharmacol. 1987;336:652\u20135.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2095_CR42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.peptides.2013.12.009","volume":"52","author":"F Gobeil Jr","year":"2014","unstructured":"Gobeil F Jr, Sirois P, Regoli D. Preclinical pharmacology, metabolic stability, pharmacokinetics and toxicology of the peptidic kinin B1 receptor antagonist R-954. Peptides. 2014;52:82\u20139.","journal-title":"Peptides"},{"key":"2095_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1515\/BC.2006.018","volume":"387","author":"BH Gabra","year":"2006","unstructured":"Gabra BH, Berthiaume N, Sirois P, Nantel F, Battistini B. The kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 diabetic neuropathy. Biol Chem. 2006;387:127\u201343.","journal-title":"Biol Chem"},{"key":"2095_CR44","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s000110300067","volume":"52","author":"S Yamaguchi-Sase","year":"2003","unstructured":"Yamaguchi-Sase S, Hayashi I, Okamoto H, Nara Y, Matsuzaki S, Hoka S, Majima M. Amelioration of hyperalgesia by kinin receptor antagonists or kininogen deficiency in chronic constriction nerve injury in rats. Inflamm Res. 2003;52:164\u20139.","journal-title":"Inflamm Res"},{"key":"2095_CR45","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1213\/01.ANE.0000130348.85587.BE","volume":"99","author":"PA Leonard","year":"2004","unstructured":"Leonard PA, Arunkumar R, Brennan TJ. Bradykinin antagonists have no analgesic effect on incisional pain. Anesth Analg. 2004;99:1166\u201372.","journal-title":"Anesth Analg"},{"key":"2095_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/08990229209144765","volume":"9","author":"AA Khan","year":"1992","unstructured":"Khan AA, Raja SN, Manning DC, Campbell JN, Meyer RA. The effects of bradykinin and sequence-related analogs on the response properties of cutaneous nociceptors in monkeys. Somatosens Mot Res. 1992;9:97\u2013106.","journal-title":"Somatosens Mot Res"},{"key":"2095_CR47","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/clpt.1991.212","volume":"50","author":"DC Manning","year":"1991","unstructured":"Manning DC, Raja SN, Meyer RA, Campbell JN. Pain and hyperalgesia after intradermal injection of bradykinin in humans. Clin Pharmacol Ther. 1991;50:721\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"2095_CR48","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.4049\/jimmunol.173.8.5219","volume":"173","author":"BC Chen","year":"2004","unstructured":"Chen BC, Yu CC, Lei HC, Chang MS, Hsu MJ, Huang CL, Chen MC, Sheu JR, Chen TF, Chen TL, Inoue H, Lin CH. Bradykinin B2 receptor mediates NF-kappaB activation and cyclooxygenase-2 expression via the Ras\/Raf-1\/ERK pathway in human airway epithelial cells. J Immunol. 2004;173:5219\u201328.","journal-title":"J Immunol"},{"key":"2095_CR49","doi-asserted-by":"publisher","first-page":"9233","DOI":"10.1128\/MCB.23.24.9233-9244.2003","volume":"2","author":"M Nie","year":"2003","unstructured":"Nie M, Pang L, Inoue H, Knox AJ. Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone h4 acetylation. Mol Cell Biol. 2003;2:9233\u201344.","journal-title":"Mol Cell Biol"},{"key":"2095_CR50","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1111\/j.1460-9568.2009.06747.x","volume":"29","author":"TI Kichko","year":"2009","unstructured":"Kichko TI, Reeh PW. TRVP1 controls acid-and heat-induced calcitonin gene-related peptide release and sensitization by bradykinin in the isolated mouse trachea. Eur J Neurosci. 2009;29:1896\u2013904.","journal-title":"Eur J Neurosci"},{"key":"2095_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neures.2008.08.004","volume":"62","author":"K Katanosaka","year":"2008","unstructured":"Katanosaka K, Banik RK, Giron R, Higashi T, Tominaga M, Mizumura K. Contribution of TRPV1 to the bradykinin nociceptive behavior and excitation of cutaneous sensory. Neurosci Res. 2008;62:168\u201375.","journal-title":"Neurosci Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-2095-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-2095-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-2095-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T10:22:04Z","timestamp":1664706124000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-2095-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2095"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-2095-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"13 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experimentation was authorized by the French Direction of Veterinary Service to J.P.G., L.M., and B.F. The study was approved by The French Animal Care and Use Committee (Comit\u00e9 r\u00e9gional d\u2019\u00e9thique pour l\u2019exp\u00e9rimentation animale Midi Pyr\u00e9n\u00e9es, ref: MP 02\/02\/02\/06).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}